![Systemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know? - Practical Dermatology Systemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know? - Practical Dermatology](https://core4-cms.imgix.net/issue-2023/1121_SF1_Table.png)
Systemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know? - Practical Dermatology
![A randomised controlled trial testing the rebound‐preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis - Olivry - Veterinary Dermatology - Wiley Online Library A randomised controlled trial testing the rebound‐preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis - Olivry - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/93d9449a-8d6a-455b-9674-dc7dc3480154/vde13134-toc-0001-m.jpg?trick=1674243472440)
A randomised controlled trial testing the rebound‐preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis - Olivry - Veterinary Dermatology - Wiley Online Library
![SOLVED: 'A nurse is teaching a client who has been taking prednisone to treat asthma and has a new prescription to discontinue the medication: The nurse should explain to the client to SOLVED: 'A nurse is teaching a client who has been taking prednisone to treat asthma and has a new prescription to discontinue the medication: The nurse should explain to the client to](https://cdn.numerade.com/ask_images/c38bd9cf831941a48082f52c3de00da0.jpg)
SOLVED: 'A nurse is teaching a client who has been taking prednisone to treat asthma and has a new prescription to discontinue the medication: The nurse should explain to the client to
![Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/520aae79-b587-419c-8002-e535cc1c647e/gr1.gif)
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet
![Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids | Pharmacological Reviews Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/72/2/414/F1.large.jpg)
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids | Pharmacological Reviews
![Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis - The Lancet Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis - The Lancet](https://www.thelancet.com/cms/attachment/2001942671/2006740904/gr1.jpg)
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis - The Lancet
![Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial - The Lancet Neurology Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/ac1a932c-21d8-4faf-9fdf-69e761addcea/gr1.gif)